Actively Recruiting

Age: 18Years +
All Genders
ID04028219

Transgender In Transition: Metabolism, Behaviour and Psychopathology in Transsexual Patients Following Hormonal Treatment

Led by Universitätsklinikum Hamburg-Eppendorf · Updated on 2022-11-08

750

Participants Needed

5

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying the effects of gender-affirming hormone therapy on individuals diagnosed with gender incongruence or gender dysphoria. This observational study aims to understand the psychological, biological, and behavioral changes caused by hormone treatments. The focus is on how sex hormones influence mental health, metabolism, and behavior over long-term use. Participants in this study undergo hormone therapy while researchers collect data through various methods. These include clinical interviews, self-rating questionnaires, behavioral experiments using virtual reality and computer games, and genetic testing from blood, stool, hair, and saliva samples. The study uses online surveys at multiple timepoints before and up to 10 years after starting hormone therapy to monitor changes. During the study, participants complete psychometric assessments and behavioral tests to measure mental health, life satisfaction, sexual health, and other psychological traits. Researchers also track side effects and social support. The main outcome is assessed using the Mini International Neuropsychiatric Interview over a 10-year period. Participants contribute data through scheduled online surveys and clinical evaluations, helping to provide a comprehensive understanding of hormone therapy's long-term effects.

CONDITIONS

Brief Title

Transgender In Transition

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of gender incongruence (ICD-11) or gender dysphoria (DSM-5)
  • Written informed consent after receiving oral and written information
  • Have not yet started gender-affirming hormonal treatment
  • Age 18 years or older
Not Eligible

You will not qualify if you...

  • Pregnancy
  • Breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 10 years

Participants complete psychometric assessments and provide biological samples to evaluate psychological, metabolic, and behavioral parameters before and after hormone therapy.

14 online surveys at baseline and at 3, 6, 9, 12, 24, 36, 48, 60, 72, 84, 96, 108, and 120 months after hormonal therapy

Trial Site Locations

Total: 5 locations

1

Universitätsklinikum Frankfurt

Frankfurt am Main, Hesse, Germany, 60590

Not Yet Recruiting

2

University Medical Center Hamburg-Eppendorf

Hamburg, Germany, 20246

Actively Recruiting

3

Medical Center of the Ludwig-Maximilians-University of Munich

Munich, Germany

Not Yet Recruiting

4

Universitätsspital Basel

Basel, Switzerland, 4031

Not Yet Recruiting

5

UniversitätsSpital Zürich

Zurich, Switzerland, 8091

Not Yet Recruiting

Loading map...

Research Team

J

Johannes Fuß, MD

J

Johanna Schröder, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Cardiovascular Health of Transgender Individuals During the ...

Gender Incongruence

Actively Recruiting

1 location

Gender Incongruence in Danish Youth (GenDa): An Observationa...

Gender Incongruence

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here